On Monday, October 2, 2017, NVHR joined Treatment Access Group and the Hepatitis Education Project to present this update on HCV DAA treatment access in the U.S. prison system. The webinar included information about newly available treatments, drug pricing in the prison system, key lawsuits, and legal tactics designed to expand access in correctional settings.
HCV Treatment Access in U.S. Prisons: Legal and Policy Challenges
- Mandy Altman, MPA
- Correctional Health Program Manager, Hepatitis Education Project
- Elizabeth Paukstis, MA, JD
- Public Policy Director, NVHR
- Annette Gaudino
- HCV/HIV Project Co-Director, Treatment Access Group